Catalyst Wire Dossier Catalyst Wire Dossier

ASACOL 400 mg

mesalamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASACOL 400 mg, covering 2010-01-08 to 2010-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis [Phase 3]

See pricing